MicroStrategy rated new Outperform at Mizuho
Securities adjusted its outlook on Intel Corporation (NASDAQ:INTC), reducing the price target from $21.00 to $20.00 while sustaining a Neutral rating on the shares. This aligns with the broader ...
Yet "the bond market has not taken on board" the potential for 3% inflation in 2025, Steven Ricchiuto, chief economist at Mizuho Securities, wrote in a Monday client note. Even before December's ...
Mizuho Securities raised its recommendation on Vornado Realty Trust (NYSE:VNO) and Cousins Properties (NYSE:CUZ), and downgraded Kilroy Realty (NYSE:KRC), considering their geographic exposure and ...
Securities expressed a positive outlook on Welltower Inc. (NYSE:WELL), an $84 billion market cap healthcare REIT that has ...
Geneos Wealth Management Inc. lessened its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 8.3% during ...
Qorvo (NASDAQ:QRVO) shares fell 0.5% in premarket trading on Friday, even as Mizuho Securities upped its earnings estimates on the involvement of activist investor Starboard Value. Mizuho analyst ...
This year’s winners from Mizuho Americas were: Serena Lin, Managing Director and Head of Agency Mortgage-Backed Securities Trading Desk for Excellence in Fix NEW YORK, Aug. 28, 2024 (GLOBE ...
Mizuho Securities USA LLC’s holdings in Amazon.com were worth $112,863,000 as of its most recent SEC filing. Other large investors also recently made changes to their positions in the company.
Securities adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE) shares, with analyst Vamil Divan increasing the price target to $9.00 from the previous $6.00, while maintaining a Neutral rating on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback